Explosive Anktiva sales, new cancer data, and fresh approvals are rapidly redefining this immunotherapy story, today, Jan. 16, 2026. ImmunityBio Today’s Change (39.11%) $1.54
Latest News
Don't Even Think About Buying CoreWeave Stock Until You Read This
Keith Noonan, The Motley Fool January 16, 2026 at 4:38 PM Key Points CoreWeave stock trades at modest price-to-sales multiples compared to its growth.
Is the stock market open on Martin Luther King Jr. Day 2026?
It’s hard to escape economic news these days, even if you’re trying to. Headlines across all media are focused on the consumer price index,
1 No-Brainer S&P 500 Index Fund to Buy Right Now for Less Than $1,000
It’s hard to beat Vanguard’s S&P 500 ETF. There are plenty of good exchange-traded funds (ETFs) costing less than $1,000 that will likely end
1 Magnificent S&P 500 Dividend Stock Down 20% to Buy and Hold Forever
James Brumley, The Motley Fool January 16, 2026 at 12:05 PM Key Points Lingering inflation has forced most consumer goods companies to make unpopular
Stock market today: Dow, S&P 500, Nasdaq slip, chip stocks rise as Wall Street ends volatile week lower
US stocks were little changed on Friday despite growing uncertainty over the next Fed chair, while strong bank earnings and ongoing geopolitical tensions capped
Elon Musk backs Warren Buffett’s ‘5-minute’ fix for America’s debt problem. But would it actually work?
Chesnot / Getty Images: J. Countess / Getty Images Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content
Introducing 'Business History': Young Warren Buffett
Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be
3 High-Yield Dividend Stocks Wall Street Thinks Will Soar 26% or More in 2026
Investors could get both high dividend yields and high returns with these stocks. Are high dividend yields joined at the hip with low share
House advances bill to restrict congressional stock trading
WASHINGTON (Gray DC) – A Republican bill in the House to regulate congressional stock trading is moving forward as lawmakers face public pressure to